Main menu button

Equity Research Enrad, Q1 2024: Better than expected start to 2024

2 May 2024

Enrad AB’s net sales of SEK 7.6 million in the first quarter exceeded our forecast of SEK 2.9 million by a considerable margin. The high sales were due to orders that were not announced in advance. Carlsquare Equity Research raises its sales and earnings forecasts for 2024-2026 by between 20 and 73%.

Good start to 2024 despite weak Swedish market

Enrad AB (“Enrad” or the “Company”) reported net sales of approximately SEK 7.6 million for Q1 2024. The day before the Q1 2024 report, Enrad sent out a press release about orders of SEK 5.3 million to its Norwegian subsidiary. Gross profit after purchases of goods and supplies was around SEK 4.3 million, compared with our estimate of around SEK 1.6 million. Operating profit after depreciation was minus SEK 1.2 million, compared with our estimate of minus SEK 1.9 million.

Enrad sells into a market for cooling and heat pumps that is affected by the interest rate situation for the important customer group of homeowners. Order intake is expected to increase from the second half of 2024, when interest rates are expected to fall. Enrad’s marketing is facilitated by the fact that the European Parliament adopted two new F-Gas regulations on 29 January 2024, in which the company has positioned itself in the segment of chillers using natural refrigerants.

Probably no need for capital in the coming quarters

Enrad’s cash and cash equivalents amounted to SEK 3.0 million on 31 March 2024, compared with SEK 6.4 million on 31 December 2023. The company has pledged its inventories through the main owner’s company. Enrad’s capital tied up in inventories amounts to SEK 20 million, of which SEK 8 million is pledged as of 31 March 2024. Management is evaluating options to secure working capital but believes that it is possible to continue operations during the remainder of 2024 without capital injection.


Carlsquare AB,, hereinafter referred to as Carlsquare, carries out activities within corporate finance and equity research and publishes, among other things, information on companies, including analyses. The information is based on sources that Carlsquare believes to be reliable. However, Carlsquare cannot guarantee the accuracy of the information. Nothing contained in the analysis should be construed as a recommendation or solicitation to invest in any financial instrument, option or the like. Opinions and conclusions expressed in the analysis are intended only for the recipient.

The content may not be copied, reproduced, or distributed to third parties without the written consent of Carlsquare. Carlsquare shall not be liable for any direct or indirect damage resulting from decisions taken based on the information contained in this analysis. Investments in financial instruments offer opportunities for capital appreciation and profits. All such investments also involve risks. Risks vary between different types of financial instruments and combinations thereof. Past performance should not be taken as an indication of future results.

The analysis is not directed at, and may not be distributed to, U.S. persons (as that term is defined in Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”)). The analysis is also not directed at any natural or legal person in any jurisdiction where the distribution of the analysis to such persons would constitute or risk a violation of any Swedish or foreign law or constitution.

The analysis is so-called Commissioned Research, where the analyzed company has signed an agreement with Carlsquare about the analysis coverage. The analyses are published on an ongoing basis during the contract period and for the usual fixed fee.

Carlsquare may or may not have a financial interest in what is the subject of this analysis. Carlsquare is committed to ensuring objectivity and independence and has established procedures for dealing with conflicts of interest.

The analysts Bertil Nilsson and Christopher Solbakke do not own and may not own shares in the company analysed.

Equity Research Enrad, Q1 2024: Better than expected start to 2024